RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS

Introduction. The anthracycline antibiotics cause clinically significant manifestations of cardiotoxicity (СТ) – myocardial injuries, reducing both quality and life expectancy of the oncological patients.The purpose of the study was to evaluate the incidence and risk factors anthracycline-induced СТ...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: N. T. Vatutin, E. V. Sklyannaya, M. A. El-Khatib, I. A. Sologub
Médium: Artigo
Jazyk:Russo
Vydáno: ABV-press 2017-10-01
Edice:Onkogematologiâ
Témata:
chemotherapy
cardiotoxicity
anthracycline-induced cardiomyopathy
risk factors
cardioprotection
On-line přístup:https://oncohematology.abvpress.ru/ongm/article/view/255
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky